| Nasdaq: ELGX
Endologix, Inc. develops, manufactures, markets, and sells innovative medical devices for the treatment of aortic disorders. The company's principal product is a stent graft and delivery system, for the treatment of abdominal aortic aneurysms through minimally-invasive endovascular repair. Its products are AFX Endovascular AAA System and IntuiTrak Powerlink System. Endologix was founded in March 1992 and is headquartered in Irvine, CA.